Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists.


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
09 Jun 2022
Historique:
received: 22 02 2022
accepted: 20 05 2022
entrez: 16 6 2022
pubmed: 17 6 2022
medline: 17 6 2022
Statut: epublish

Résumé

Formyl peptide receptor 2 (FPR2) agonists have shown efficacy in inflammatory-driven animal disease models and have the potential to treat a range of diseases. Many reported synthetic agonists contain a phenylurea, which appears to be necessary for activity in the reported chemotypes. We set out to find isosteres for the phenylurea and focused our efforts on heteroaryl rings. The wide range of potencies with heterocyclic isosteres demonstrates how electronic effects of the heteroatom placement impact molecular recognition. Herein, we report our discovery of benzimidazole and aminophenyloxadiazole FPR2 agonists with low nanomolar activity.

Identifiants

pubmed: 35707160
doi: 10.1021/acsmedchemlett.2c00079
pmc: PMC9190041
doi:

Types de publication

Journal Article

Langues

eng

Pagination

943-948

Informations de copyright

© 2022 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Bioorg Med Chem Lett. 2002 Nov 4;12(21):3125-8
pubmed: 12372516
Trends Pharmacol Sci. 2015 Nov;36(11):737-755
pubmed: 26478210
Nat Rev Drug Discov. 2016 Aug;15(8):551-67
pubmed: 27020098
J Med Chem. 2020 Sep 10;63(17):9003-9019
pubmed: 32407089
FASEB J. 2017 Apr;31(4):1273-1288
pubmed: 28087575
J Med Chem. 2015 Jan 22;58(2):537-59
pubmed: 25365541
Expert Opin Ther Pat. 2016 Oct;26(10):1139-1156
pubmed: 27454150
Br J Pharmacol. 2014 Sep;171(17):4087-96
pubmed: 24824742
Eur J Med Chem. 2021 Mar 5;213:113167
pubmed: 33486199
RSC Med Chem. 2021 May 13;12(7):1046-1064
pubmed: 34355177
Semin Immunol. 2016 Apr;28(2):137-45
pubmed: 27021499
Nat Rev Immunol. 2013 Jan;13(1):59-66
pubmed: 23197111
JACC Basic Transl Sci. 2021 Aug 23;6(8):676-689
pubmed: 34466754
Nat Commun. 2022 Feb 25;13(1):1054
pubmed: 35217703
Stem Cells. 2017 Mar;35(3):654-665
pubmed: 27790799

Auteurs

Nicholas R Wurtz (NR)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

James A Johnson (JA)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Andrew Viet (A)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Pravin S Shirude (PS)

Biocon Bristol Myers Squibb R&D Center, Bangalore-560099, India.

Vishweshwaraiah Baligar (V)

Biocon Bristol Myers Squibb R&D Center, Bangalore-560099, India.

Sudhakara Madduri (S)

Biocon Bristol Myers Squibb R&D Center, Bangalore-560099, India.

Daniel L Cheney (DL)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Hyunsoo Park (H)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

John A Lupisella (JA)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Mei-Yin Hsu (MY)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Mojgan Abousleiman (M)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Michael A Galella (MA)

Bristol Myers Squibb Research and Development, New Brunswick, New Jersey 08901, United States.

Darpandeep Aulakh (D)

Bristol Myers Squibb Research and Development, New Brunswick, New Jersey 08901, United States.

Elizabeth A Dierks (EA)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Ricardo A Garcia (RA)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Jacek Ostrowski (J)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Ellen K Kick (EK)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Ruth R Wexler (RR)

Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, United States.

Classifications MeSH